CLINICAL PHARMACOLOGY OF DRUGS AFFECTING HEMOSTASIS

Abstract

This article provides an extended clinical-pharmacological analysis of drugs influencing hemostasis, including anticoagulants, antiplatelet agents, fibrinolytics, coagulants, and hemostatic adjuncts. Special emphasis is placed on their mechanisms of action, pharmacokinetics, therapeutic use, safety considerations, and monitoring strategies in clinical practice. The paper integrates evidence-based guidelines, global clinical practices, and modern therapeutic approaches, offering a holistic view of hemostasis-modifying medications and their role in managing thrombotic and hemorrhagic disorders.